Anuja Dokras
YOU?
Author Swipe
View article: SAT-133 Addition of Metformin Does Not Alter Metabolic Impact of Combined Oral Contraceptive Pills in Hyperandrogenic Women with Polycystic Ovary Syndrome: Findings from COMET-PCOS Trial
SAT-133 Addition of Metformin Does Not Alter Metabolic Impact of Combined Oral Contraceptive Pills in Hyperandrogenic Women with Polycystic Ovary Syndrome: Findings from COMET-PCOS Trial Open
Disclosure: C.M. Stetter: None. W.C. Dodson: None. C. Coutifaris: None. OBJECTIVE: Combined oral contraceptive pills (COCPs) are used as first-line treatment for polycystic ovary syndrome (PCOS), which is associated with increased cardiova…
View article: The Invisible Burden: Examining the Impact of Exposure Misclassification in Epidemiologic Analyses of Uterine Fibroids
The Invisible Burden: Examining the Impact of Exposure Misclassification in Epidemiologic Analyses of Uterine Fibroids Open
Background Uterine fibroids, a common gynaecologic condition, are often underdiagnosed, potentially biasing results in epidemiologic studies due to measurement error. Objectives To examine how varying sensitivity in detecting uterine fibro…
View article: Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey
Polycystic ovary syndrome perspectives from patients and health professionals on clinical features, current name, and renaming: a longitudinal international online survey Open
View article: A Conversational Agent Using Natural Language Processing for Postpartum Care for New Mothers: Development and Engagement Analysis
A Conversational Agent Using Natural Language Processing for Postpartum Care for New Mothers: Development and Engagement Analysis Open
Background The “fourth trimester,” or postpartum time period, remains a critical phase of pregnancy that significantly impacts parents and newborns. Care poses challenges due to complex individual needs as well as low attendance rates at r…
View article: Combined Hormonal Contraceptives, Metformin or Both for Management of Polycystic Ovary Syndrome (COMET-PCOS): A Randomized Clinical
Combined Hormonal Contraceptives, Metformin or Both for Management of Polycystic Ovary Syndrome (COMET-PCOS): A Randomized Clinical Open
View article: International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women’s health condition
International PCOS guideline clinical research priorities roadmap: a co-designed approach aligned with end-user priorities in a neglected women’s health condition Open
The survey, International PCOS Guideline Network and 2018 and 2023 International PCOS Guidelines were funded by the Australian National Health and Medical Research Council (NHMRC) Centres of Research excellence in PCOS (APP1078444) and in …
View article: Lack of adequate counseling about pregnancy complications in patients with polycystic ovary syndrome: a cross-sectional survey study
Lack of adequate counseling about pregnancy complications in patients with polycystic ovary syndrome: a cross-sectional survey study Open
Despite the high prevalence of obstetric complications associated with PCOS, our study revealed inadequate patient counseling about both the antepartum and postpartum periods and preconception management of existing comorbidities. Our find…
View article: Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis
Sexual function in women with polycystic ovary syndrome: a systematic review and meta-analysis Open
BACKGROUND Polycystic ovary syndrome (PCOS) is a common and distressing endocrine disorder associated with lower quality of life, subfertility, diabetes, cardiovascular disease, depression, anxiety, and eating disorders. PCOS characteristi…
View article: LIMITED ADOPTION OF CURRENT POLYCYSTIC OVARY SYNDROME (PCOS) RELATED INFERTILITY TREATMENT GUIDELINES BY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY (REI) SPECIALISTS IN THE UNITED STATES (U.S.)
LIMITED ADOPTION OF CURRENT POLYCYSTIC OVARY SYNDROME (PCOS) RELATED INFERTILITY TREATMENT GUIDELINES BY REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY (REI) SPECIALISTS IN THE UNITED STATES (U.S.) Open
View article: Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome Open
This effort was primarily funded by the Australian Government via the National Health Medical Research Council (NHMRC) (APP1171592), supported by a partnership with American Society for Reproductive Medicine, Endocrine Society, European So…
View article: Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome Open
STUDY QUESTION What is the recommended assessment and management of those with polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise, and consumer preference? SUMMARY ANSWER International evidence-based…
View article: Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome
Recommendations From the 2023 International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome Open
Study Question What is the recommended assessment and management of those with polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise, and consumer preference? Summary Answer International evidence-based…
View article: Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome Open
Study question What is the recommended assessment and management of those with polycystic ovary syndrome (PCOS), based on the best available evidence, clinical expertise, and consumer preference? Summary answer International evidence-based…
View article: Outcomes of assisted reproductive technology procedures performed on weekdays versus weekends: a retrospective cohort study
Outcomes of assisted reproductive technology procedures performed on weekdays versus weekends: a retrospective cohort study Open
View article: Considerations in the Treatment of Depression and Anxiety in Women with PCOS
Considerations in the Treatment of Depression and Anxiety in Women with PCOS Open
Women with polycystic ovary syndrome (PCOS) are known to be at a greater risk of depression and anxiety. What is less clear is whether existing treatments for PCOS are effective in managing this increased risk and what the optimal approach…
View article: Genetics in reproductive endocrinology and infertility
Genetics in reproductive endocrinology and infertility Open
View article: Beyond awareness – National Infertility Awareness Week 2023
Beyond awareness – National Infertility Awareness Week 2023 Open
View article: Risk of severe acute respiratory syndrome coronavirus 2 infection among women with polycystic ovary syndrome
Risk of severe acute respiratory syndrome coronavirus 2 infection among women with polycystic ovary syndrome Open
View article: Endometrial thickness: How thin is too thin?
Endometrial thickness: How thin is too thin? Open
View article: Female Adult Acne and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee
Female Adult Acne and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee Open
In endocrine and reproductive endocrine literature, adult female acne is considered as a possible clinical expression of hyperandrogenism, with most polycystic ovary syndrome (PCOS) guidelines considering acne as a condition of androgen ex…
View article: Innovation in reproductive medicine: time to reimagine and redesign
Innovation in reproductive medicine: time to reimagine and redesign Open
View article: Implementation of international guidelines for polycystic ovary syndrome: barriers and facilitators among gynecologists and primary care providers
Implementation of international guidelines for polycystic ovary syndrome: barriers and facilitators among gynecologists and primary care providers Open
Our study highlights the need for interventions that target the barriers identified among gynecologists and PCPs in implementing guidelines for diagnosing and managing PCOS. In conjunction with prior studies, our findings support a multidi…
View article: Response to Letter to the Editor From Jialal: “Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Disease: A Longitudinal Study”
Response to Letter to the Editor From Jialal: “Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Disease: A Longitudinal Study” Open
View article: Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Syndrome: A Longitudinal Study
Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Syndrome: A Longitudinal Study Open
Context Cross-sectional studies have identified an increased risk of metabolic syndrome (MetSyn) in women with polycystic ovary syndrome (PCOS), but longitudinal data are limited and primarily include White and European cohorts. Objective …
View article: Licogliflozin versus placebo in women with polycystic ovary syndrome: A randomized, double‐blind, phase 2 trial
Licogliflozin versus placebo in women with polycystic ovary syndrome: A randomized, double‐blind, phase 2 trial Open
Polycystic ovary syndrome (PCOS) is characterized by hyperandrogenism and insulin resistance. The dual sodium‐glucose co‐transporter 1/2 inhibitor (SGLT1/2i) licogliflozin (LIK066) ameliorates hyperinsulinism in patients with diabetes and …
View article: Author response for "Licogliflozin versus placebo in women with polycystic ovary syndrome: A randomized, double‐blind, phase 2 trial"
Author response for "Licogliflozin versus placebo in women with polycystic ovary syndrome: A randomized, double‐blind, phase 2 trial" Open
View article: Racial differences in anxiety, depression, and quality of life in women with polycystic ovary syndrome
Racial differences in anxiety, depression, and quality of life in women with polycystic ovary syndrome Open
View article: Table of Contents
Table of Contents Open
View article: Licogliflozin <i>versus</i> Placebo in Women with Polycystic Ovary Syndrome (PCOS): A Randomised, Double-Blind, Phase 2 Trial
Licogliflozin <i>versus</i> Placebo in Women with Polycystic Ovary Syndrome (PCOS): A Randomised, Double-Blind, Phase 2 Trial Open
View article: Update on PCOS: Consequences, Challenges, and Guiding Treatment
Update on PCOS: Consequences, Challenges, and Guiding Treatment Open
Polycystic ovary syndrome (PCOS) is one of the most common reproductive endocrine disorders in women and despite this, diagnostic challenges, delayed diagnosis, and less-than-optimal treatment regimens plague the condition. The Internation…